✦ LIBER ✦

Myeloproliferative disorder therapy: assessment and management of adverse events—a cardiologist's perspective

✍ Scribed by Dermot Kenny

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 64 KB
Volume: 27
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.911

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Although some cardiac effects, such as palpitations and tachycardia, occur commonly in healthy people, they have also been shown to be associated with agents used to treat the myeloproliferative disorders. Various strategies exist to prevent and manage cardiac effects and minimise their impact on treatment compliance and persistence. These include pre‐therapy cardiac assessment, pharmacological intervention and referral to a cardiologist. Ultimately, treating physicians must use their discretion when deciding which management strategy to use and which cardiac side effects require referral to a cardiologist, but the value of continuous dialogue between specialists should not be ignored. Copyright © 2009 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Myeloproliferative disorder therapy: ass

Myeloproliferative disorder therapy: assessment and management of adverse events—a dermatologist's perspective

✍ Boutros Soutou; Sélim Aractingi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract Development of cutaneous manifestations in patients with myeloproliferative disorders can be either due to the course of the disease itself or induced by some of the treatments given. The cutaneous manifestations may reveal an unknown haemopathy and/or indicate a poor prognosis. Some of

Myeloproliferative disorder therapy: ass

Myeloproliferative disorder therapy: assessment and management of adverse events—a psychiatrist's perspective

✍ Graeme McDonald 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

## Abstract Chronic diseases such as the myeloproliferative disorders may mask a worsening emotional state in patients, which can be exacerbated by the addition of common treatments such as interferon‐__α__. Management of mood disturbances is best considered from the first consultation, as the nega

Anagrelide for thrombocytosis in myelopr

Anagrelide for thrombocytosis in myeloproliferative disorders : A prospective study to assess efficacy and adverse event profile

✍ Michael Steurer; Guenther Gastl; Wieslaw-Wiktor Jedrzejczak; Robert Pytlik; Wern 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Adverse childhood events are associated

Adverse childhood events are associated with obesity and disordered eating: Results from a U.S. population-based survey of young adults

✍ Bernard F. Fuemmeler; Eric Dedert; F. Joseph McClernon; Jean C. Beckham 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

## Abstract The authors investigated the relationship between childhood abuse and obesity in young adulthood (M age = 22) in a large, U.S. representative sample (N = 15,197). Controlling for demographics and depression, men with a history of childhood sexual abuse were at increased risk of overweig